| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Cornelia Weyand | Q87638981 |
| P2093 | author name string | Jörg J Goronzy | |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 160-9 | |
| P577 | publication date | 2003-07-10 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Medium- and large-vessel vasculitis | |
| P478 | volume | 349 |
| Q64042421 | Q64042421 |
| Q92511204 | 14-3-3ζ-A Novel Immunogen Promotes Inflammatory Cytokine Production |
| Q39716942 | A Case of Membranous Glomerulonephropathy Associated with Takayasu's Arteritis. |
| Q40353912 | A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis |
| Q44651268 | A case of MPO-ANCA-positive polyarteritis nodosa complicated by exudative otitis media, mononeuritis multiplex, and acute renal failure |
| Q83103509 | A case of Takayasu's disease presenting as severe secondary hypertension, with angiographic improvement following medical treatment |
| Q79785631 | A case of common variable immunodeficiency syndrome associated with Takayasu arteritis |
| Q37165309 | A case of concentric left ventricular hypertrophy with falsely normal blood pressure in patient with Takayasu's arteritis |
| Q40341999 | A case of microscopic polyangiitis associated with aortic valve insufficiency |
| Q40491909 | A case of myeloperoxidase-antineutrophil cytoplasmic antibody positive-polyarteritis nodosa complicated by interstitial pneumonia and rapidly progressive renal failure |
| Q40431069 | A case of pulmonary asbestosis presenting with temporal arteritis involving multiple medium-sized vessels |
| Q90468059 | A new era for giant cell arteritis |
| Q36399030 | Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis |
| Q79764644 | An uneven expression of T cell receptor V genes in the arterial wall and peripheral blood in giant cell arteritis |
| Q42372650 | An unusual finding in a 57-year-old woman with new onset hypertension and a diastolic murmur. |
| Q41818068 | An unusual presentation of classic idiopathic polyarteritis nodosa as acute interstitial nephritis. |
| Q35817852 | Anemia in a middle aged female with aortitis: a case report |
| Q27687590 | Anti-TNF-alpha therapy and systemic vasculitis |
| Q34377764 | Anti-cytokine treatment for Takayasu arteritis: State of the art |
| Q57279273 | Association of NOS2 and potential effect of VEGF, IL6, CCL2 and IL1RN polymorphisms and haplotypes on susceptibility to GCA--a simultaneous study of 130 potentially functional SNPs in 14 candidate genes |
| Q36681865 | Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases |
| Q37138017 | Autoimmunity in atherosclerosis: a protective response losing control? |
| Q60609505 | B-Symptomatik und Kauclaudicatio bei einem 79-jährigen Patienten |
| Q42021533 | Blocking the NOTCH pathway inhibits vascular inflammation in large-vessel vasculitis |
| Q93036340 | CD28 Signaling Controls Metabolic Fitness of Pathogenic T Cells in Medium and Large Vessel Vasculitis |
| Q80542463 | Cardioembolism: a rare cause of jaw claudication |
| Q90289950 | Cardiogenic shock as the first manifestation of large vessel vasculitis in a young patient: case report |
| Q57753646 | Chapter 8 Gastrointestinal Involvement in Systemic Vasculitis |
| Q36990068 | Characterization of the inflammatory cells in ascending thoracic aortic aneurysms in patients with Marfan syndrome, familial thoracic aortic aneurysms, and sporadic aneurysms |
| Q40290985 | Chronic periaortitis with thoracic aorta and epiaortic artery involvement: a systemic large vessel vasculitis? |
| Q90911186 | Clinical Factors Associated with Time-Specific Distribution of 18F-Fluorodeoxyglucose in Large-Vessel Vasculitis |
| Q48362032 | Clinical characteristics and outcomes of 61 patients with chronic periaortitis including IgG4-related and non-IgG4-related cases |
| Q37313119 | Clinical features of polyarteritis nodosa in Korea |
| Q27005821 | Clinical practice. Giant-cell arteritis and polymyalgia rheumatica |
| Q37289670 | Clinicopathologic correlations in giant cell arteritis: a retrospective study of 107 cases |
| Q55367689 | Co-Presentation of Giant Cell Arteritis and Granulomatosis with Polyangiitis: A Case Report and Review of Literature. |
| Q35786299 | Combined medical, surgical and endovascular treatment of a giant cell arteritis case manifesting as upper limbs acute ischemia. |
| Q94348364 | Commentary |
| Q40329752 | Complete atherosclerotic occlusion of infra-renal aorta and bilateral renal artery stenosis |
| Q30301251 | Conditions presenting with symptoms of peripheral arterial disease |
| Q40231628 | Crohn's disease and Takayasu's arteritis: an uncommon association. |
| Q49644349 | Cross-phenotype analysis of Immunochip data identifies KDM4C as a relevant locus for the development of systemic vasculitis. |
| Q91650552 | Cytokines, growth factors and proteases in medium and large vessel vasculitis |
| Q34510423 | Delayed contrast-enhanced MRI of the coronary artery wall in takayasu arteritis |
| Q38599488 | Diagnosis, Management, and Outcome of Aortitis at a Single Center |
| Q90139237 | Diagnostic performance and utility of very high-resolution ultrasonography in diagnosing giant cell arteritis of the temporal artery |
| Q34691595 | Diagnostic value of high-resolution MR imaging in giant cell arteritis |
| Q28743290 | Discovering disease associations by integrating electronic clinical data and medical literature |
| Q37174386 | Drug insight: anti-tumor necrosis factor therapies for the vasculitic diseases |
| Q40492114 | Early diagnosis of vasculitides |
| Q37696633 | Echocardiographic characteristics of pulmonary artery involvement in Takayasu arteritis |
| Q35688053 | Effect of diabetes mellitus on giant cell arteritis |
| Q60919809 | Endovascular treatment of critical lower limb ischemia caused by giant cell arteritis |
| Q34442812 | Enhanced expression of the soluble form of E-selectin attenuates progression of lupus nephritis and vasculitis in MRL/lpr mice |
| Q36692409 | Fatal aortic dissection in a patient with giant cell arteritis: a case report and review of the literature |
| Q38632019 | Gangrene in Takayasu's arteritis: a report of two cases and review of literature |
| Q41348284 | Gelatinase expression and proteolytic activity in giant-cell arteritis |
| Q49552169 | Giant Cell (Temporal) Arteritis with Persistent Bilateral Sensorineural Hearing Loss - A Likely Consequence of Delayed Institution of Glucocorticoid Therapy |
| Q28070137 | Giant Cell Arteritis and Polymyalgia Rheumatica: 2016 Update |
| Q36992669 | Giant Cell Arteritis: From Pathogenesis to Therapeutic Management. |
| Q90635834 | Giant Cell Arteritis: The Experience of Two Collaborative Referral Centers and an Overview of Disease Pathogenesis and Therapeutic Advancements |
| Q79333480 | Giant cell arteritis |
| Q37479388 | Giant cell arteritis and angiogenesis: a review |
| Q34449862 | Giant cell arteritis exclusively detected by 18F-fluorodeoxyglucose positron emission tomography: a case report |
| Q34236040 | Giant cell arteritis or tension-type headache?: A differential diagnostic dilemma |
| Q53288451 | Giant cell arteritis presenting as dysarthria and mediastinal mass. |
| Q36735753 | Giant cell arteritis with spontaneous remission |
| Q37204521 | Giant cell arteritis: a systemic vascular disease |
| Q35617577 | Giant cell arteritis: immune and vascular aging as disease risk factors |
| Q38919828 | Giant cell arteritis: ophthalmic manifestations of a systemic disease |
| Q92464575 | Giant cell arteritis: pathogenic mechanisms and new potential therapeutic targets |
| Q46469656 | Glucocorticoids: importance in the treatment of vasculitis |
| Q40349428 | Headache attributed to arteritis, cerebral venous thrombosis, and other vascular intracranial disturbances. |
| Q44034328 | Hepatitis C Virus-Associated Aortitis Caused by Type I Cryoglobulins |
| Q24678930 | Histological parameters helpful in recognising steroid-treated temporal arteritis: an analysis of 35 cases |
| Q37004746 | Histopathological Characteristics of Distal Middle Cerebral Artery in Adult and Pediatric Patients with Moyamoya Disease |
| Q34750121 | Homozygous mutation in SAMHD1 gene causes cerebral vasculopathy and early onset stroke |
| Q34847819 | IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritis |
| Q90170365 | Identification of two major autoantigens negatively regulating endothelial activation in Takayasu arteritis |
| Q28302095 | Imaging procedures for giant cell arteritis (Horton's disease) |
| Q34777989 | Immune aging and autoimmunity |
| Q34036703 | Immune aging and rheumatoid arthritis |
| Q38897019 | Immune checkpoint dysfunction in large and medium vessel vasculitis |
| Q34777943 | Immune mechanisms in medium and large-vessel vasculitis |
| Q42321741 | Immunoinhibitory checkpoint deficiency in medium and large vessel vasculitis. |
| Q30843370 | Incidence of giant cell arteritis and characteristics of patients: data-driven analysis of comorbidities |
| Q33926070 | Incidentally diagnosed Takayasu arteritis on thyroid ultrasonography showing prominent collateral vessels of thyroidal arteries and common carotid artery occlusion |
| Q37206968 | Increased risk of peripheral arterial disease in polymyalgia rheumatica: a population-based cohort study |
| Q37405713 | Infection and vasculitis |
| Q33805176 | Inflammatory and autoimmune reactions in atherosclerosis and vaccine design informatics |
| Q55265655 | Inflammatory and infectious aortic diseases. |
| Q59130566 | Infliximab biosimilar CT-P13 therapy in patients with Takayasu arteritis with low dose of glucocorticoids: a prospective single-arm study |
| Q51782127 | Influence of corticosteroid treatment on MRI findings in giant cell arteritis. |
| Q47279406 | Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis. |
| Q36421038 | Insights into imaging of aortitis |
| Q30429445 | Interleukin 17 in vascular inflammation |
| Q58621638 | Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis |
| Q38829766 | Interleukin-9 and T helper type 9 cells in rheumatic diseases. |
| Q34377832 | Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum. |
| Q43511814 | Is TNF-α really involved in giant cell arteritis pathogenesis? |
| Q35991932 | Is giant cell arteritis an infectious disease? Biological and epidemiological evidence |
| Q42794025 | Large vessel arteritis: a diagnostic challenge in the elderly. |
| Q46624379 | Large vessel vasculitis developed early after allogeneic bone marrow transplant for acute erythroid leukemia. |
| Q38529556 | MDS and GCA: a prognostic dilemma |
| Q26825052 | Macrophages in vascular inflammation--From atherosclerosis to vasculitis |
| Q34743180 | Magnetic resonance angiography in extracranial giant cell arteritis |
| Q35936110 | Magnetic resonance imaging findings in giant cell arteritis |
| Q36667809 | Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides. |
| Q53310581 | Molecular imaging of vascular inflammation. |
| Q39366956 | Multiple ischemic vertebrobasilar lesions in temporal arteritis |
| Q26783463 | Neuro-Ophthalmological Emergencies |
| Q35770620 | Non-atherosclerotic coronary pathology causing sudden death. |
| Q30431621 | Non-invasive imaging of vascular inflammation. |
| Q38545044 | Nonatherosclerotic PAD: Approach to Exertional Pain in the Lower Extremities |
| Q61755946 | PET/CT and PET/MRI in Neurology: Infection/Inflammation |
| Q41027560 | Pediatric-onset Takayasu's arteritis: clinical features and short-term outcome. |
| Q40368272 | Perivascular carotid inflammation: an unusual case of carotidynia. |
| Q34205665 | Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management |
| Q81668995 | Polymyalgia rheumatica and giant-cell arteritis |
| Q39356029 | Pro-inflammatory and anti-inflammatory T cells in giant cell arteritis. |
| Q21195258 | Progress in treatment of ANCA-associated vasculitis |
| Q40494608 | Pulmonary complications of Behcet's disease and Takayasu's arteritis |
| Q36065341 | Rare Case of Takayasu Arteritis with Concurrent Aneurysmal Dilation and Stenosis |
| Q52611166 | Recent Advances in Giant Cell Arteritis. |
| Q38189191 | Recent advances in Takayasu arteritis |
| Q89521443 | Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib |
| Q64247941 | Reviewing the Pathophysiology Behind the Advances in the Management of Giant Cell Arteritis |
| Q40181046 | Role of cardiovascular echo in patients with Takayasu arteritis |
| Q56942323 | Selective up-regulation of the soluble pattern-recognition receptor pentraxin 3 and of vascular endothelial growth factor in giant cell arteritis: Relevance for recent optic nerve ischemia |
| Q35058267 | Serpin treatment suppresses inflammatory vascular lesions in temporal artery implants (TAI) from patients with giant cell arteritis |
| Q43216374 | Serum amyloid A is a useful marker to evaluate the disease activity of Takayasu's arteritis. |
| Q47671088 | Sex, Symptom Severity, and Quality of Life in Rheumatology |
| Q57818786 | Single-Nucleotide Polymorphism of the MLX Gene Is Associated With Takayasu Arteritis |
| Q37940604 | Subtleties in the histopathology of giant cell arteritis |
| Q83208307 | Sudden death due to giant cell coronary arteritis |
| Q37192834 | T cells in arteritis and atherosclerosis |
| Q37324840 | T cells in rheumatoid arthritis |
| Q47123805 | TSPO PET Imaging: From Microglial Activation to Peripheral Sterile Inflammatory Diseases? |
| Q48224613 | Tacrolimus therapy for dermal arteritis of the nasal philtrum refractory to surgery and anti-inflammatory therapy (doxycycline/niacinamide and topical fluocinolone) in a dog. |
| Q58552082 | Takayasu Arteritis |
| Q88601161 | Takayasu arteritis with coronary and pulmonary involvement in a young child presenting with acute coronary syndrome |
| Q37769408 | Takayasu arteritis--advances in diagnosis and management |
| Q54188689 | Takayasu arteritis. |
| Q36722666 | Takayasu arteritis: consideration of pulmonary involvement |
| Q36727177 | Takayasu arteritis: imaging spectrum at multidetector CT angiography |
| Q64044949 | Takayasu's arteritis |
| Q46106025 | Temporal expression of inflammatory mediators in brain basilar artery vasculitis and cerebrospinal fluid of rabbits with coccidioidal meningitis |
| Q36823653 | Tertiary Lymphoid Organs in Takayasu Arteritis |
| Q58621591 | Th1 and Th17 Cytokines Drive Inflammation in Takayasu Arteritis |
| Q33723160 | Th17 and Th1 T-cell responses in giant cell arteritis |
| Q64270066 | The Microbiome of Temporal Arteries |
| Q37560012 | The Role of Immunogenicity in Cardiovascular Disease |
| Q50647528 | The development of autoimmune features in aging mice is closely associated with alterations of the peripheral CD4⁺ T-cell compartment. |
| Q42735210 | The enigma of vasculitis |
| Q40628928 | The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis? |
| Q40067370 | The immunoinhibitory PD-1/PD-L1 pathway in inflammatory blood vessel disease. |
| Q27021465 | The immunopathology of giant cell arteritis: diagnostic and therapeutic implications |
| Q36821429 | The length of superficial temporal artery biopsies |
| Q38915556 | The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease |
| Q34461224 | The treatment of giant cell arteritis |
| Q36577546 | Therapy insight: The recognition and treatment of retinal manifestations of systemic vasculitis |
| Q38787301 | Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis--a prospective longitudinal study |
| Q37317964 | Toll-like receptors 4 and 5 induce distinct types of vasculitis |
| Q53096424 | Towards an optimal semiquantitative approach in giant cell arteritis: an (18)F-FDG PET/CT case-control study. |
| Q36663141 | Treatment of chronic inflammatory diseases with biologic agents: opportunities and risks for the elderly |
| Q45034871 | Treatment with statins does not exhibit a clinically relevant corticosteroid-sparing effect in patients with giant cell arteritis |
| Q37548004 | Two Subsets of Large Vessel Vasculitis Characterized by the Absence or Presence of Spondyloarthritis or its Associated Diseases |
| Q37860204 | Unusual headaches in the elderly |
| Q33605954 | Update on the management of giant cell arteritis |
| Q54577008 | Utility of contrast-enhanced ultrasound for the assessment of the carotid artery wall in patients with Takayasu or giant cell arteritis. |
| Q34743236 | Vascular damage in giant cell arteritis |
| Q36388695 | Vascular dendritic cells in giant cell arteritis |
| Q34189036 | Vasculitis in Systemic Sclerosis |
| Q36130959 | Vasculitis: mechanisms involved and clinical manifestations |
| Q37357843 | Vessel-specific Toll-like receptor profiles in human medium and large arteries |
| Q37492198 | Widespread headache as the first clinical manifestation of giant cell arteritis in patients affected by polymyalgia rheumatica |
| Q83217519 | [Clinical and serological findings of giant-cell arteritis] |
| Q30248636 | [Diagnostics and treatment of polymyalgia rheumatica]. |
| Q79210271 | [Fatal giant cell arteritis with severe bilateral involvement of the vertebral arteries] |
| Q82846825 | [Giant cell arteritis (temporal arteritis). Pathophysiology, immunology] |
| Q84108145 | [Giant cell arteritis: etiological knowledge and diagnostic challenge for pathologists] |
| Q85397949 | [Giant-cell arteritis: update: diagnosis and therapy] |
| Q84077008 | [Histopathology of systemic vasculitis] |
| Q84137100 | [Large vessel vasculitis] |
| Q84542819 | [Magnetic resonance angiography in rheumatology] |
| Q83335587 | [New pathogenetic aspects in primary systemic vasculitides] |
| Q83367074 | [Pathogenesis of medium- and large-vessel vasculitis] |
| Q83593739 | [Vasculitis: histopathology and differential diagnosis] |
Search more.